Rhythm Pharmaceuticals Ownership | Who Owns Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals Ownership Summary
Rhythm Pharmaceuticals is owned by 104.47% institutional investors, 0.65% insiders. Blackrock is the largest institutional shareholder, holding 11.21% of RYTM shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 4.68% of its assets in Rhythm Pharmaceuticals shares.
RYTM Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Rhythm Pharmaceuticals | 104.47% | 0.65% | -5.11% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 6.74M | 11.21% | $276.82M |
Blackrock funding, inc. /de | 6.27M | 9.84% | $396.05M |
Baker bros. advisors lp | 5.60M | 8.80% | $354.15M |
Ra capital management | 5.56M | 8.73% | $351.42M |
Primecap management co/ca/ | 4.88M | 7.66% | $308.24M |
Vanguard group | 3.44M | 5.62% | $192.72M |
Nea management company | 2.91M | 4.57% | $183.88M |
Perceptive advisors | 2.42M | 3.80% | $152.81M |
State street | 2.00M | 3.33% | $82.28M |
Goldman sachs group | 1.81M | 2.96% | $101.45M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Checkpoint capital | 727.98K | 20.74% | $40.75M |
Nea management company | 2.91M | 13.84% | $183.88M |
Ra capital management | 5.56M | 5.92% | $351.42M |
Perceptive advisors | 2.42M | 5.67% | $152.81M |
Opaleye management | 500.00K | 4.90% | $27.99M |
Nan fung group | 49.12K | 4.89% | $3.10M |
Silverarc capital management | 400.77K | 4.67% | $25.32M |
Stempoint capital lp | 176.75K | 3.58% | $11.17M |
Baker bros. advisors lp | 5.60M | 3.44% | $354.15M |
Rock springs capital management lp | 861.15K | 3.39% | $54.42M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Polar capital | 1.25M | 0.41% | 750.87K |
Janus henderson group | 1.22M | 0.03% | 621.43K |
Adage capital partners gp | 341.00K | 0.04% | 341.00K |
Morgan stanley | 475.65K | 0.00% | 292.78K |
Westfield capital management co lp | 1.63M | 0.43% | 288.38K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Goldman sachs group | 1.81M | 0.02% | -2.07M |
Healthcare of ontario pension plan trust fund | - | - | -1.11M |
State street | 2.00M | 0.00% | -1.01M |
Primecap management co/ca/ | 4.88M | 0.24% | -909.28K |
Frazier life sciences management | - | - | -678.76K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Adage capital partners gp | 341.00K | 0.04% | 341.00K | $21.55M |
Norges bank | 205.65K | 0.00% | 205.65K | $11.51M |
Artisan partners limited partnership | 174.48K | 0.02% | 174.48K | $11.03M |
Nomura | 157.30K | 0.01% | 157.30K | $6.46M |
Logos global management lp | 130.00K | 0.91% | 130.00K | $8.21M |
Sold Out
Holder | Change |
---|---|
Ifp advisors | -1.00 |
Innealta capital | -7.00 |
Covestor | -10.00 |
Hexagon capital partners | -11.00 |
Ronald blue trust | -15.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 236 | -0.42% | 66,529,034 | 4.29% | 104 | 1.02% | 124 | -3.88% | 76 | 7.04% |
Mar 31, 2025 | 238 | 12.26% | 64,653,938 | -0.38% | 102 | 0.91% | 130 | 11.11% | 72 | 26.32% |
Dec 31, 2024 | 197 | 5.35% | 58,110,291 | -14.09% | 94 | 0.78% | 112 | 20.43% | 50 | -12.28% |
Sep 30, 2024 | 187 | 7.47% | 67,638,955 | -2.40% | 110 | 0.83% | 93 | 3.33% | 57 | 9.62% |
Jun 30, 2024 | 174 | -1.14% | 69,303,085 | 1.97% | 115 | 0.90% | 90 | 2.27% | 52 | -5.45% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
PRIMECAP Odyssey Aggressive Growth | 3.09M | 4.68% | -779.65K |
Vanguard Total Stock Mkt Idx Inv | 2.02M | 3.05% | -51.22K |
Vanguard US Total Market Shares ETF | 1.92M | 3.03% | 2.33K |
PRIMECAP Odyssey Growth | 1.53M | 2.32% | -111.43K |
iShares Russell 2000 ETF | 1.28M | 1.93% | -24.36K |
Polar Capital Biotech S Inc | 1.25M | 1.89% | - |
Federated Hermes Kaufmann Small Cap A | 742.00K | 1.12% | 1.93K |
Federated Hermes Kaufmann Small Cap Grow | 742.00K | 1.12% | 1.93K |
Federated Hermes Kaufmann R | 733.00K | 1.11% | 41.70K |
Federated Hermes Kaufmann Growth | 733.00K | 1.11% | 41.70K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 02, 2025 | Shulman Joseph | Chief Technical Officer | Sell | $1.77M |
Aug 21, 2025 | Shulman Joseph | Chief Technical Officer | Sell | $419.09K |
Aug 12, 2025 | Smith Hunter C | Chief Financial Officer | Sell | $2.37M |
Aug 13, 2025 | Smith Hunter C | Chief Financial Officer | Sell | $333.79K |
Aug 12, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | $142.50K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 19 |
2025 Q2 | - | 16 |
2025 Q1 | - | 35 |
2024 Q4 | - | 9 |
2024 Q3 | - | 17 |
RYTM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools